About Us
Weiye Biotech (Quanzhou Veyea Biomedical Technology Co., Ltd.) was established in December 2018 and was recognized as a High-Tech Enterprise of Fujian Province in 2021.
Core Business: Weiye Biotech specializes in the R&D and manufacturing of cell culture media, and has successfully developed six proprietary products.
Regulatory Qualifications: As one of the few companies in China capable of independently developing and mass-producing culture media, Weiye Biotech’s six culture media products have obtained both medical device manufacturing and product registrations with the National Medical Products Administration (NMPA).
Quality System: The company operates under a comprehensive quality management system in full compliance with the Good Manufacturing Practice (GMP) for Medical Devices.。
Weiye Biotech upholds the core philosophy of “stability, high quality, and traceability,” and is committed to providing compliant, safe, and reliable key raw materials for stem cell and immune cell therapies. We firmly believe that culture media are not only the foundation of research and manufacturing, but also the essential driver that advances life sciences toward clinical translation and large-scale industrial application.
Technological Moat
27+ patents (covering formulation design and process optimization) and six products registered with the NMPA, Weiye Biotech has built a strong competitive edge. Each serum-free formulation has undergone over five years of dedicated R&D, making it extremely difficult for peers to replicate. This positions Weiye Biotech as a frontrunner in the serum-free culture media sector.
Collaborative Innovation
10+national-level research and clinical institutions, driving joint breakthroughs across science and medicine.
First-Mover Advantage in Regulatory Filing
6+culture media series products successfully registered with the NMPA, Weiye Biotech meets both the requirements for clinical cell therapy and the national regulatory framework. This early compliance establishes a strong competitive edge across downstream applications.
Weiye Biotech upholds the core philosophy of “stability, high quality, and traceability,” and is committed to providing compliant, safe, and reliable key raw materials for stem cell and immune cell therapies. We firmly believe that culture media are not only the foundation of research and production, but also the essential driver that advances life sciences toward clinical translation and industrial application.
In terms of R&D, Weiye Biotech adheres to independent innovation and has established a comprehensive technology platform covering formulation design, component optimization, production processes, and quality control. This enables the company to build strong technological barriers and maintain continuous iteration capabilities. Our scientific team brings together professionals from cell biology, immunology, and translational medicine, and maintains long-term collaborations with leading research institutes and clinical organizations, ensuring that our products truly meet the needs of both research and clinical applications.
In production and quality control, the company strictly follows the GMP quality system, with facilities and testing platforms that meet international standards. By implementing a robust quality inspection process, we ensure the stability and traceability of every batch, consistently guaranteeing critical parameters such as cell expansion efficiency, purity, and viability, thereby providing safe and reliable solutions for our customers.
Looking ahead, Weiye Biotech is not only focused on current applications in stem cell and immune cell therapies, but is also actively expanding into emerging fields such as exosomes, organoids, and iPSCs. By continuously broadening our product portfolio and technological scope, we aim to remain at the forefront of life sciences. We believe that as the field rapidly evolves, cell therapy will become a major pillar of modern medicine — and Weiye Biotech’s mission is to provide a solid foundation for this industry, accelerating the translation of cutting-edge research into clinical practice.
Driven by science, guided by compliance, and bound by social responsibility, Weiye Biotech is committed to becoming a trusted global supplier of cell culture media, transforming the progress of medicine into a force that safeguards human health.